This characteristic of high Ki67 expression was similar to the findings in the dataset of resected LNs from the HNSCC that did not receive ICB treatment, where CD39+ Tpex cells had higher Ki67 expression rates than CD39+ dTex cells (Fig. S3J). This evidence concerns the gene MKI67 and head and neck squamous cell carcinoma.